Newave Pharmaceutical

Newave Pharmaceutical is a clinical-stage company primarily focused on the discovery and development of novel therapies for cancer treatment. We have a world-class MedChem team that mainly pursues clinically validated targets with significant unmet needs, challenging medicinal chemistry, and strong interest from large pharmaceutical companies, especially targets with strong synergy in the Bcl-2 pathway. Our drug design team is dedicated to the rational design of highly differentiated patented drug candidates. Our clinical team has extensive experience in rapidly completing Proof of Concept (POC) and pivotal studies in both China and the United States. We strive to provide the latest generation of drugs for cancer patients worldwide.